ResMed Inc. (ASX: RMD)
Australia
· Delayed Price · Currency is AUD
31.40
+0.24 (0.77%)
May 31, 2024, 2:10 AM EDT
ResMed Revenue
ResMed had revenue of $4.43B USD in the twelve months ending March 31, 2024, with 10.37% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.20B USD with 7.17% year-over-year growth. In the fiscal year ending June 30, 2023, ResMed had annual revenue of $4.22B USD with 32.10% growth.
Revenue (ttm)
$4.43B
Revenue Growth
+10.37%
P/S Ratio
6.93
Revenue / Employee
$437,094
Employees
10,140
Market Cap
46.13B AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 4.22B | 1.03B | 32.10% |
Jun 30, 2022 | 3.20B | 239.81M | 8.11% |
Jun 30, 2021 | 2.96B | 350.44M | 13.44% |
Jun 30, 2020 | 2.61B | - | - |
Jun 30, 2019 | 2.61B | 266.38M | 11.38% |
Jun 30, 2018 | 2.34B | 273.46M | 13.23% |
Jun 30, 2017 | 2.07B | 228.02M | 12.40% |
Jun 30, 2016 | 1.84B | 159.80M | 9.52% |
Jun 30, 2015 | 1.68B | 123.94M | 7.97% |
Jun 30, 2014 | 1.55B | 40.52M | 2.68% |
Jun 30, 2013 | 1.51B | 145.94M | 10.66% |
Jun 30, 2012 | 1.37B | 125.37M | 10.08% |
Jun 30, 2011 | 1.24B | 150.79M | 13.80% |
Jun 30, 2010 | 1.09B | 171.62M | 18.64% |
Jun 30, 2009 | 920.74M | 85.34M | 10.22% |
Jun 30, 2008 | 835.40M | 119.07M | 16.62% |
Jun 30, 2007 | 716.33M | 109.34M | 18.01% |
Jun 30, 2006 | 607.00M | 181.49M | 42.65% |
Jun 30, 2005 | 425.51M | 86.17M | 25.39% |
Jun 30, 2004 | 339.34M | 65.77M | 24.04% |
Jun 30, 2003 | 273.57M | 69.49M | 34.05% |
Jun 30, 2002 | 204.08M | 48.92M | 31.53% |
Jun 30, 2001 | 155.16M | 39.54M | 34.20% |
Jun 30, 2000 | 115.62M | 27.02M | 30.49% |
Jun 30, 1999 | 88.60M | 22.10M | 33.23% |
Jun 30, 1998 | 66.50M | 17.30M | 35.16% |
Jun 30, 1997 | 49.20M | 14.60M | 42.20% |
Jun 30, 1996 | 34.60M | 11.10M | 47.23% |
Jun 30, 1995 | 23.50M | 9.60M | 69.06% |
Jun 30, 1994 | 13.90M | 6.20M | 80.52% |
Jun 30, 1993 | 7.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 31.82B |
Cochlear Limited | 2.18B |
Fisher & Paykel Healthcare Corporation Limited | 1.56B |
Pro Medicus Limited | 142.12M |
Sonic Healthcare Limited | 8.21B |
Ramsay Health Care Limited | 15.96B |
Telix Pharmaceuticals Limited | 502.55M |
Neuren Pharmaceuticals Limited | 231.93M |
ResMed News
- 4 days ago - $100 Invested In ResMed 20 Years Ago Would Be Worth This Much Today - Benzinga
- 4 days ago - Derelict sites in Enniscorthy identified for compulsory purchase as council tackles housing shortages - Independent Ireland
- 10 days ago - Here's How Much a $1000 Investment in ResMed Made 10 Years Ago Would Be Worth Today - Benzinga
- 10 days ago - Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy - GlobeNewsWire
- 17 days ago - ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy - GlobeNewsWire
- 21 days ago - 2024 AMVCA: Saga, Ebuka, RMD, other red carpet stand-out looks (PHOTOS) - Premium Times Nigeria
- 4 weeks ago - How Sage Capital is making money from other investors’ panic - The Australian Financial Review
- 5 weeks ago - Decoding ResMed Inc (RMD): A Strategic SWOT Insight - GuruFocus